In 2007, Alli was approved for OTC use for weight loss in overweight adults. Between 1999 and October 2008, 32 reports of serious liver injury, including 6 cases of liver failure, in patients using orlistat were submitted to the FDA. In August 2009, the FDA initiated a safety review of Alli side effects to determine if there is a direct relationship between reports of liver injury and diet drugs containing orlistat. The FDA issued an early communication on August 24, 2009, indicating that they were reviewing this new safety information, but no definite association between liver injury and Alli has been established. The FDA currently recommends that consumers continue using Alli as directed.
Alli Liver Damage and Liver Failure
The U.S. Food and Drug Administration’s reports included six cases of liver failure and 27 of the incidents resulted in hospitalization. The most commonly reported liver problems with Alli were a yellowing of the skin or whites of the eyes known as jaundice, weakness and abdominal pain.
Alli Side Effects
Serious side effects from taking Alli for weight loss include:
- Weakness
- Fatigue
- Fever
- Brown urine
- Jaundice
- Liver damage
- Liver failure
Speak to an Alli Lawyer
If you took Alli for weight loss and suffered serious liver damage, or liver failure, we encourage you to contact an Alli litigation attorney at our law firm immediately. An experienced product liability attorney can assist you in a legal action against the makers of Alli, GlaxoSmithKline, PLC. You are not alone. Join other Alli liver damage victims and their families in fighting for their legal rights.
Please fill out our free legal evaluation form on the far right and we will call or e-mail you back within 24 hours. Please keep in mind that certain states have a statute of limitations that limits the amount of time you have to file an Alli lawsuit or seek legal action. Contact our law firm immediately so we may explain the rights and options available to you and your family.
The FDA has received 32 reports of serious liver damage possibly connected to the use of orlistat-based drugs like Alli.
Accutane (isotretinoin), or Roaccutane as it is known in other parts of the world, was discovered in 1979 and released in 1982 by Hoffmann-La Roche. Accutane was given to patients to treat severe acne because it affects all four ways that acne develops. Most Accutane patients reacted with dramatic and permanent clearing of their acne symptoms. Accutane is a vitamin A derivative (13-cis-retinoic acid) which is administered orally in pill form, for 15 to 20 weeks. Accutane was originally only prescribed to patients with severe acne that did not respond to other forms of acne treatments. However, over the past 25 years Accutane has gained in popularity and is being prescribed not only more frequently, but also for less severe acne. This practice is controversial because Accutane increases a patient’s risk of developing serious side effects such as 
A medical study in the Journal of Orthopedic Trauma links Fosamax to a rare type of fracture in the femur. The small, observational study looked at 70 patients who experienced low-energy femur fractures, which occur when someone falls from a standing height or less. Twenty-five patients (36%) were taking Fosamax on average for four years or more. The Fosamax patients’ fractures had some distinct characteristics: nineteen (76%) of the 25 patients had a simple fracture with a straight line across the bone and a beak-like overhang on one side. Also, the patients’ bones didn’t look like typical osteoporotic bone; they looked strong.

